Germany pharmaceuticals medical tenders

Ex-Ante Transparency Announcement Contract According To § 130C Sgb V Drug Tremfya (R) Active Ingredient: Guselkumab Atc Code: L04Ac16

Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.

Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24

Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24

Open House Drug Discount Agreements Calcipotriol And Betamethasone, Excluding Ointments, Atc D05Ax22

Bri­Vu­Din 125Mg Ta­Blet­Te

Completion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From June 1St, 2024 To Usually May 31St, 2026

Open House Drug Discount Agreements Calcipotriol And Betamethasone, Excluding Ointments, Atc D05Ax22

Brivudin 125Mg Tablette

Brivudine 125Mg Tablet